Constellation Pharmaceuticals Inc. (CNST) NASDAQ/NGS (GLOBAL SELECT MARKET)

$33.99 0 (0.00%)

Market Cap: $0

As of 07/14/21 12:00 AM EDT. Market open.

(CNST)

Constellation Pharmaceuticals Inc. (CNST) NASDAQ/NGS (GLOBAL SELECT MARKET)

$33.99 0 (0.00%)

Market Cap: $0

As of 07/14/21 12:00 AM EDT. Market open.

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease ... read more

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease progression and drug resistance. Constellation is driving development of the BET inhibitor CPI-0610 for the treatment of myelofibrosis as well as the EZH2 inhibitor CPI-0209 for the treatment of solid tumors. The Company is also applying its broad research and development capabilities to explore other novel targets that directly and indirectly impact gene expression to fuel a sustainable pipeline of innovative small-molecule product candidates. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$427,551
CEO Compensation (Total)
$4.70M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$427,551
CEO Compensation (Total)
$4.70M
Address
.
KEY STATS
Open
$34
Previous Close
$33.99
Days Range
$33.97 - $34.05
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
47,914,690
Open
$34
Previous Close
$33.99
Days Range
$33.97 - $34.05
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
47,914,690

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CONSTELLATION PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Reeve Emma Chief Financial Officer Feb 19, 2021 Option Exercise $8.04 4,010 32,240 4,010 Feb 23, 2021, 05:58 PM
Reeve Emma Chief Financial Officer Feb 22, 2021 Option Exercise $8.04 6,260 50,330 6,260 Feb 23, 2021, 05:58 PM
Reeve Emma Chief Financial Officer Feb 22, 2021 Sale $37.60 6,260 235,374 0 Feb 23, 2021, 05:58 PM
Reeve Emma Chief Financial Officer Feb 19, 2021 Sale $37.71 4,010 151,218 0 Feb 23, 2021, 05:58 PM
COLUMN GROUP L P 10% Owner Feb 17, 2021 Sale $36.95 10,000 369,503 99,155 Feb 19, 2021, 05:32 PM
COLUMN GROUP L P 10% Owner Feb 17, 2021 Sale $36.95 10,000 369,503 99,155 Feb 19, 2021, 05:31 PM
Reeve Emma Chief Financial Officer Feb 18, 2021 Option Exercise $8.04 1,100 8,844 1,100 Feb 19, 2021, 04:17 PM
Reeve Emma Chief Financial Officer Feb 17, 2021 Option Exercise $8.04 410 3,296 410 Feb 19, 2021, 04:17 PM
Reeve Emma Chief Financial Officer Feb 17, 2021 Sale $37.56 410 15,398 0 Feb 19, 2021, 04:17 PM
Reeve Emma Chief Financial Officer Feb 18, 2021 Sale $37.58 1,100 41,343 0 Feb 19, 2021, 04:17 PM
Valentine Karen See Remarks Jan 19, 2021 Option Exercise $11.50 17,203 197,835 17,203 Jan 20, 2021, 05:56 PM
Valentine Karen See Remarks Jan 19, 2021 Sale $33.97 17,203 584,463 8,430 Jan 20, 2021, 05:56 PM
GOLDSMITH MARK A Director Dec 21, 2020 Sale $35.02 4,020 140,769 139,043 Dec 28, 2020, 04:02 PM
Reeve Emma Chief Financial Officer Dec 21, 2020 Option Exercise $6.81 5,720 38,975 5,720 Dec 22, 2020, 04:53 PM
Reeve Emma Chief Financial Officer Dec 21, 2020 Sale $35.11 5,720 200,805 0 Dec 22, 2020, 04:53 PM
COLUMN GROUP L P 10% Owner Dec 14, 2020 Option Exercise $1.55 30,107 46,666 2,584,957 Dec 16, 2020, 06:42 PM
COLUMN GROUP L P 10% Owner Dec 14, 2020 Option Exercise $1.55 30,107 46,666 2,584,957 Dec 16, 2020, 06:40 PM
Reeve Emma Chief Financial Officer Jun 08, 2020 Option Exercise $7.60 589 4,476 589 Jun 10, 2020, 06:50 PM
Reeve Emma Chief Financial Officer Jun 08, 2020 Sale $37.55 589 22,118 377 Jun 10, 2020, 06:50 PM
Audia James E Director May 12, 2020 Sale $50.10 6,100 305,622 25,434 May 13, 2020, 06:30 PM
Senderowicz Adrian Chief Medical Officer May 12, 2020 Option Exercise $5.51 9,357 51,557 25,241 May 13, 2020, 06:30 PM
Senderowicz Adrian Chief Medical Officer May 12, 2020 Sale $50.18 9,357 469,488 15,884 May 13, 2020, 06:30 PM
GOLDSMITH MARK A Director May 12, 2020 Option Exercise $4.12 4,225 17,399 147,288 May 13, 2020, 06:29 PM
GOLDSMITH MARK A Director May 11, 2020 Option Exercise $1.55 100 155 143,163 May 13, 2020, 06:29 PM
GOLDSMITH MARK A Director May 11, 2020 Sale $50.00 100 5,000 143,063 May 13, 2020, 06:29 PM
GOLDSMITH MARK A Director May 12, 2020 Sale $50.05 4,225 211,474 143,063 May 13, 2020, 06:29 PM
Raythatha Jigar See Remarks May 12, 2020 Option Exercise $5.51 9,209 50,742 24,170 May 13, 2020, 06:25 PM
Raythatha Jigar See Remarks May 11, 2020 Option Exercise $5.51 26 143 14,987 May 13, 2020, 06:25 PM
Raythatha Jigar See Remarks May 11, 2020 Sale $50.00 26 1,300 14,961 May 13, 2020, 06:25 PM
Raythatha Jigar See Remarks May 12, 2020 Sale $50.17 9,209 461,981 14,961 May 13, 2020, 06:25 PM
Reeve Emma Chief Financial Officer May 11, 2020 Option Exercise $8.92 16,062 143,269 16,062 May 12, 2020, 09:41 PM
Reeve Emma Chief Financial Officer May 08, 2020 Option Exercise $9.85 12,741 125,467 12,741 May 12, 2020, 09:41 PM
Reeve Emma Chief Financial Officer May 08, 2020 Sale $49.53 12,741 631,055 0 May 12, 2020, 09:41 PM
Reeve Emma Chief Financial Officer May 11, 2020 Sale $49.53 16,062 795,623 0 May 12, 2020, 09:41 PM
Trojer Patrick Chief Scientific Officer May 06, 2020 Option Exercise $7.04 10,000 70,385 10,000 May 07, 2020, 04:39 PM
Trojer Patrick Chief Scientific Officer May 06, 2020 Sale $45.16 10,000 451,553 0 May 07, 2020, 04:39 PM
Valentine Karen See Remarks May 05, 2020 Option Exercise $11.50 4,744 54,556 4,744 May 07, 2020, 04:34 PM
Valentine Karen See Remarks May 06, 2020 Option Exercise $10.96 12,566 137,749 12,566 May 07, 2020, 04:34 PM
Valentine Karen See Remarks May 06, 2020 Sale $40.10 12,566 503,897 0 May 07, 2020, 04:34 PM
Valentine Karen See Remarks May 05, 2020 Sale $40.01 4,744 189,817 0 May 07, 2020, 04:34 PM
Audia James E Director May 06, 2020 Sale $45.15 7,500 338,599 31,534 May 07, 2020, 04:28 PM
GOLDSMITH MARK A Director May 05, 2020 Option Exercise $3.50 3,145 11,006 146,208 May 07, 2020, 04:25 PM
GOLDSMITH MARK A Director May 06, 2020 Option Exercise $4.26 11,463 48,825 154,526 May 07, 2020, 04:25 PM
GOLDSMITH MARK A Director May 05, 2020 Sale $40.01 3,145 125,824 143,063 May 07, 2020, 04:25 PM
GOLDSMITH MARK A Director May 06, 2020 Sale $45.06 11,463 516,545 143,063 May 07, 2020, 04:25 PM
GOLDSMITH MARK A Director Apr 27, 2020 Option Exercise $1.55 400 620 143,463 Apr 29, 2020, 08:20 PM
GOLDSMITH MARK A Director Apr 27, 2020 Sale $40.12 400 16,049 143,063 Apr 29, 2020, 08:20 PM
Valentine Karen See Remarks Apr 27, 2020 Option Exercise $11.50 400 4,600 400 Apr 29, 2020, 08:03 PM
Valentine Karen See Remarks Apr 27, 2020 Sale $40.13 400 16,052 0 Apr 29, 2020, 08:03 PM
Valentine Karen See Remarks Apr 20, 2020 Option Exercise $11.50 789 9,074 789 Apr 22, 2020, 08:17 PM
Valentine Karen See Remarks Apr 20, 2020 Sale $33.65 789 26,550 0 Apr 22, 2020, 08:17 PM
Reeve Emma Chief Financial Officer Apr 17, 2020 Option Exercise $6.61 760 5,024 760 Apr 20, 2020, 05:53 PM
Reeve Emma Chief Financial Officer Apr 17, 2020 Sale $35.29 760 26,820 0 Apr 20, 2020, 05:53 PM
Valentine Karen See Remarks Apr 16, 2020 Option Exercise $11.50 2,998 34,477 2,998 Apr 20, 2020, 05:52 PM
Valentine Karen See Remarks Apr 17, 2020 Option Exercise $11.50 2,300 26,450 2,300 Apr 20, 2020, 05:52 PM
Valentine Karen See Remarks Apr 16, 2020 Sale $33.57 2,998 100,637 1,043 Apr 20, 2020, 05:52 PM
Valentine Karen See Remarks Apr 17, 2020 Sale $35.19 2,300 80,939 0 Apr 20, 2020, 05:52 PM
Reeve Emma Chief Financial Officer Apr 14, 2020 Option Exercise $8.76 1,225 10,731 1,225 Apr 16, 2020, 02:31 PM
Reeve Emma Chief Financial Officer Apr 14, 2020 Sale $35.20 1,225 43,123 0 Apr 16, 2020, 02:31 PM
Valentine Karen See Remarks Apr 09, 2020 Option Exercise $8.76 635 5,563 635 Apr 13, 2020, 04:56 PM
Valentine Karen See Remarks Apr 09, 2020 Sale $35.02 635 22,236 0 Apr 13, 2020, 04:56 PM
Reeve Emma Chief Financial Officer Apr 09, 2020 Option Exercise $7.78 700 5,449 589 Apr 13, 2020, 04:55 PM
Reeve Emma Chief Financial Officer Apr 09, 2020 Sale $35.02 700 24,513 0 Apr 13, 2020, 04:55 PM
COLUMN GROUP L P 10% Owner Mar 20, 2020 Buy $23.15 5,539 128,228 6,051,376 Mar 23, 2020, 06:59 PM
COLUMN GROUP L P 10% Owner Mar 19, 2020 Buy $22.38 36,135 808,701 6,045,837 Mar 23, 2020, 06:59 PM
COLUMN GROUP L P 10% Owner Mar 20, 2020 Buy $23.15 5,539 128,228 6,051,376 Mar 23, 2020, 06:57 PM
COLUMN GROUP L P 10% Owner Mar 19, 2020 Buy $22.38 36,135 808,701 6,045,837 Mar 23, 2020, 06:57 PM
Valentine Karen See Remarks Mar 09, 2020 Option Exercise $8.76 617 5,405 617 Mar 11, 2020, 04:11 PM
Valentine Karen See Remarks Mar 09, 2020 Sale $32.03 617 19,763 465 Mar 11, 2020, 04:11 PM
Reeve Emma Chief Financial Officer Feb 12, 2020 Option Exercise $8.04 1,103 8,868 1,103 Feb 14, 2020, 05:09 PM
Reeve Emma Chief Financial Officer Feb 13, 2020 Option Exercise $8.04 5,521 44,389 5,521 Feb 14, 2020, 05:09 PM
Reeve Emma Chief Financial Officer Feb 12, 2020 Sale $35.02 1,103 38,624 0 Feb 14, 2020, 05:09 PM
Reeve Emma Chief Financial Officer Feb 13, 2020 Sale $35.06 5,521 193,539 0 Feb 14, 2020, 05:09 PM
Valentine Karen See Remarks Feb 12, 2020 Option Exercise $11.50 1,500 17,250 1,500 Feb 14, 2020, 05:09 PM
Valentine Karen See Remarks Feb 13, 2020 Option Exercise $10.33 4,473 46,217 4,473 Feb 14, 2020, 05:09 PM
Valentine Karen See Remarks Feb 12, 2020 Sale $35.02 1,500 52,527 0 Feb 14, 2020, 05:09 PM
Valentine Karen See Remarks Feb 13, 2020 Sale $35.07 4,473 156,859 0 Feb 14, 2020, 05:09 PM
Valentine Karen See Remarks Feb 10, 2020 Option Exercise $11.14 14,096 157,035 14,096 Feb 13, 2020, 06:22 PM
Valentine Karen See Remarks Feb 11, 2020 Option Exercise $11.50 8,550 98,325 8,550 Feb 13, 2020, 06:22 PM
Valentine Karen See Remarks Feb 10, 2020 Sale $33.51 14,096 472,357 0 Feb 13, 2020, 06:22 PM
Valentine Karen See Remarks Feb 11, 2020 Sale $35.03 8,550 299,506 0 Feb 13, 2020, 06:22 PM
Reeve Emma Chief Financial Officer Feb 10, 2020 Option Exercise $7.60 200 1,520 200 Feb 12, 2020, 05:36 PM
Reeve Emma Chief Financial Officer Feb 11, 2020 Option Exercise $7.67 8,642 66,308 7,212 Feb 12, 2020, 05:36 PM
Reeve Emma Chief Financial Officer Feb 10, 2020 Sale $35.00 200 7,000 0 Feb 12, 2020, 05:36 PM
Reeve Emma Chief Financial Officer Feb 11, 2020 Sale $35.04 8,642 302,816 0 Feb 12, 2020, 05:36 PM
Valentine Karen See Remarks Feb 10, 2020 Option Exercise $11.50 14,096 162,104 14,096 Feb 12, 2020, 05:36 PM
Valentine Karen See Remarks Feb 11, 2020 Option Exercise $11.50 8,550 98,325 8,550 Feb 12, 2020, 05:36 PM
Valentine Karen See Remarks Feb 10, 2020 Sale $33.51 14,096 472,357 0 Feb 12, 2020, 05:36 PM
Valentine Karen See Remarks Feb 11, 2020 Sale $35.03 8,550 299,506 0 Feb 12, 2020, 05:36 PM
EVNIN ANTHONY B Director Dec 13, 2019 Buy $34.50 400,000 13,800,000 5,742,765 Dec 16, 2019, 05:57 PM
Venrock Healthcare Capital Partners III, L.P. 10% Owner Dec 13, 2019 Buy $34.50 400,000 13,800,000 4,016,873 Dec 16, 2019, 05:56 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner Nov 12, 2019 Sale $32.77 12,800 419,456 2,110,290 Nov 13, 2019, 08:31 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner Nov 08, 2019 Sale $30.33 174,316 5,287,179 2,197,406 Nov 13, 2019, 08:31 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner Nov 12, 2019 Sale $32.77 12,800 419,456 2,111,290 Nov 12, 2019, 09:19 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner Nov 08, 2019 Sale $30.26 1,074,316 32,512,179 2,197,406 Nov 12, 2019, 09:19 PM
Senderowicz Adrian Chief Medical Officer Nov 06, 2019 Option Exercise $5.51 27,232 150,048 43,116 Nov 08, 2019, 05:28 PM
Senderowicz Adrian Chief Medical Officer Nov 06, 2019 Sale $28.12 27,232 765,849 37,685 Nov 08, 2019, 05:28 PM
Reeve Emma Chief Financial Officer Nov 06, 2019 Option Exercise $6.75 65,626 442,781 65,626 Nov 08, 2019, 05:01 PM
Reeve Emma Chief Financial Officer Nov 06, 2019 Sale $21.50 65,626 1,410,775 63,052 Nov 08, 2019, 05:01 PM
Trojer Patrick Chief Scientific Officer Nov 06, 2019 Option Exercise $6.12 37,920 231,890 46,142 Nov 08, 2019, 05:01 PM
Trojer Patrick Chief Scientific Officer Nov 06, 2019 Sale $25.07 46,142 1,156,854 34,607 Nov 08, 2019, 05:01 PM
Audia James E Director Nov 06, 2019 Sale $18.55 22,500 417,411 57,034 Nov 08, 2019, 05:00 PM
Raythatha Jigar See Remarks Nov 06, 2019 Option Exercise $5.51 102,750 566,153 117,711 Nov 08, 2019, 05:00 PM
Raythatha Jigar See Remarks Nov 06, 2019 Sale $28.33 102,750 2,911,381 100,331 Nov 08, 2019, 05:00 PM
Reeve Emma Chief Financial Officer Nov 05, 2019 Option Exercise $6.61 1,000 6,610 1,000 Nov 07, 2019, 04:44 PM
Reeve Emma Chief Financial Officer Nov 05, 2019 Sale $15.50 1,000 15,504 0 Nov 07, 2019, 04:44 PM
Audia James E Director Nov 05, 2019 Sale $15.01 2,288 34,351 61,534 Nov 06, 2019, 04:26 PM
Trojer Patrick Chief Scientific Officer Nov 05, 2019 Option Exercise $5.51 1,150 6,337 9,372 Nov 06, 2019, 04:26 PM
Trojer Patrick Chief Scientific Officer Nov 04, 2019 Option Exercise $5.51 100 551 8,322 Nov 06, 2019, 04:26 PM
Trojer Patrick Chief Scientific Officer Nov 05, 2019 Sale $15.01 1,150 17,256 8,222 Nov 06, 2019, 04:26 PM
Trojer Patrick Chief Scientific Officer Nov 04, 2019 Sale $15.00 100 1,500 8,222 Nov 06, 2019, 04:26 PM
Trojer Patrick Chief Scientific Officer Oct 23, 2019 Option Exercise $5.51 300 1,653 8,522 Oct 24, 2019, 03:45 PM
Trojer Patrick Chief Scientific Officer Oct 22, 2019 Option Exercise $5.29 7,930 41,977 18,207 Oct 24, 2019, 03:45 PM
Trojer Patrick Chief Scientific Officer Oct 23, 2019 Sale $15.20 300 4,559 8,222 Oct 24, 2019, 03:45 PM
Trojer Patrick Chief Scientific Officer Oct 22, 2019 Sale $15.00 9,985 149,802 8,222 Oct 24, 2019, 03:45 PM
Audia James E Director Oct 23, 2019 Sale $15.15 200 3,029 63,822 Oct 24, 2019, 03:44 PM
Audia James E Director Oct 22, 2019 Sale $15.01 5,012 75,213 64,022 Oct 24, 2019, 03:44 PM
COLUMN GROUP L P 10% Owner Oct 03, 2019 Buy $8.50 80,000 680,000 159,155 Oct 07, 2019, 05:35 PM
COLUMN GROUP L P 10% Owner Oct 03, 2019 Buy $8.50 1,331,764 11,319,994 6,009,702 Oct 07, 2019, 05:35 PM
EVNIN ANTHONY B Director Oct 03, 2019 Buy $8.50 2,823,529 23,999,997 5,342,765 Oct 04, 2019, 05:33 PM
Senderowicz Adrian Chief Medical Officer Dec 13, 2018 Option Exercise $5.51 15,884 87,521 15,884 Dec 17, 2018, 04:46 PM
TEPPER ROBERT I Director Aug 22, 2018 Option Exercise $1.55 51,032 79,100 3,034,083 Aug 24, 2018, 04:05 PM
THIRD ROCK VENTURES LP 10% Owner Aug 22, 2018 Option Exercise $1.55 51,032 79,100 3,034,083 Aug 24, 2018, 04:05 PM
THIRD ROCK VENTURES LP 10% Owner Jul 23, 2018 Buy $15.00 266,667 4,000,005 2,983,051 Jul 24, 2018, 07:19 PM
TEPPER ROBERT I Director Jul 23, 2018 Buy $15.00 266,667 4,000,005 2,983,051 Jul 24, 2018, 07:15 PM
ORBIMED ADVISORS LLC 10% Owner Jul 23, 2018 Buy $15.00 200,000 3,000,000 417,921 Jul 24, 2018, 04:46 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner Jul 23, 2018 Buy $15.00 133,333 1,999,995 2,297,406 Jul 23, 2018, 08:15 PM
Casdin Capital, LLC 10% Owner Jul 23, 2018 Buy $15.00 266,667 4,000,005 612,450 Jul 23, 2018, 08:12 PM
EVNIN ANTHONY B Director Jul 23, 2018 Buy $15.00 133,334 2,000,010 2,519,236 Jul 23, 2018, 08:04 PM
Alexandria Venture Investments, LLC 10% Owner Jul 23, 2018 Buy $15.00 66,667 1,000,005 216,304 Jul 23, 2018, 04:54 PM
Flynn James E 10% Owner Jul 23, 2018 Buy $15.00 200,000 3,000,000 835,843 Jul 23, 2018, 01:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Reeve Emma Chief Financial Officer 02/19/2021 32,240
Reeve Emma Chief Financial Officer 02/22/2021 50,330
Reeve Emma Chief Financial Officer 02/22/2021 235,374
Reeve Emma Chief Financial Officer 02/19/2021 151,218
COLUMN GROUP L P 10% Owner 02/17/2021 369,503
COLUMN GROUP L P 10% Owner 02/17/2021 369,503
Reeve Emma Chief Financial Officer 02/18/2021 8,844
Reeve Emma Chief Financial Officer 02/17/2021 3,296
Reeve Emma Chief Financial Officer 02/17/2021 15,398
Reeve Emma Chief Financial Officer 02/18/2021 41,343
Valentine Karen See Remarks 01/19/2021 197,835
Valentine Karen See Remarks 01/19/2021 584,463
GOLDSMITH MARK A Director 12/21/2020 140,769
Reeve Emma Chief Financial Officer 12/21/2020 38,975
Reeve Emma Chief Financial Officer 12/21/2020 200,805
COLUMN GROUP L P 10% Owner 12/14/2020 46,666
COLUMN GROUP L P 10% Owner 12/14/2020 46,666
Reeve Emma Chief Financial Officer 06/08/2020 4,476
Reeve Emma Chief Financial Officer 06/08/2020 22,118
Audia James E Director 05/12/2020 305,622
Senderowicz Adrian Chief Medical Officer 05/12/2020 51,557
Senderowicz Adrian Chief Medical Officer 05/12/2020 469,488
GOLDSMITH MARK A Director 05/12/2020 17,399
GOLDSMITH MARK A Director 05/11/2020 155
GOLDSMITH MARK A Director 05/11/2020 5,000
GOLDSMITH MARK A Director 05/12/2020 211,474
Raythatha Jigar See Remarks 05/12/2020 50,742
Raythatha Jigar See Remarks 05/11/2020 143
Raythatha Jigar See Remarks 05/11/2020 1,300
Raythatha Jigar See Remarks 05/12/2020 461,981
Reeve Emma Chief Financial Officer 05/11/2020 143,269
Reeve Emma Chief Financial Officer 05/08/2020 125,467
Reeve Emma Chief Financial Officer 05/08/2020 631,055
Reeve Emma Chief Financial Officer 05/11/2020 795,623
Trojer Patrick Chief Scientific Officer 05/06/2020 70,385
Trojer Patrick Chief Scientific Officer 05/06/2020 451,553
Valentine Karen See Remarks 05/05/2020 54,556
Valentine Karen See Remarks 05/06/2020 137,749
Valentine Karen See Remarks 05/06/2020 503,897
Valentine Karen See Remarks 05/05/2020 189,817
Audia James E Director 05/06/2020 338,599
GOLDSMITH MARK A Director 05/05/2020 11,006
GOLDSMITH MARK A Director 05/06/2020 48,825
GOLDSMITH MARK A Director 05/05/2020 125,824
GOLDSMITH MARK A Director 05/06/2020 516,545
GOLDSMITH MARK A Director 04/27/2020 620
GOLDSMITH MARK A Director 04/27/2020 16,049
Valentine Karen See Remarks 04/27/2020 4,600
Valentine Karen See Remarks 04/27/2020 16,052
Valentine Karen See Remarks 04/20/2020 9,074
Valentine Karen See Remarks 04/20/2020 26,550
Reeve Emma Chief Financial Officer 04/17/2020 5,024
Reeve Emma Chief Financial Officer 04/17/2020 26,820
Valentine Karen See Remarks 04/16/2020 34,477
Valentine Karen See Remarks 04/17/2020 26,450
Valentine Karen See Remarks 04/16/2020 100,637
Valentine Karen See Remarks 04/17/2020 80,939
Reeve Emma Chief Financial Officer 04/14/2020 10,731
Reeve Emma Chief Financial Officer 04/14/2020 43,123
Valentine Karen See Remarks 04/09/2020 5,563
Valentine Karen See Remarks 04/09/2020 22,236
Reeve Emma Chief Financial Officer 04/09/2020 5,449
Reeve Emma Chief Financial Officer 04/09/2020 24,513
COLUMN GROUP L P 10% Owner 03/20/2020 128,228
COLUMN GROUP L P 10% Owner 03/19/2020 808,701
COLUMN GROUP L P 10% Owner 03/20/2020 128,228
COLUMN GROUP L P 10% Owner 03/19/2020 808,701
Valentine Karen See Remarks 03/09/2020 5,405
Valentine Karen See Remarks 03/09/2020 19,763
Reeve Emma Chief Financial Officer 02/12/2020 8,868
Reeve Emma Chief Financial Officer 02/13/2020 44,389
Reeve Emma Chief Financial Officer 02/12/2020 38,624
Reeve Emma Chief Financial Officer 02/13/2020 193,539
Valentine Karen See Remarks 02/12/2020 17,250
Valentine Karen See Remarks 02/13/2020 46,217
Valentine Karen See Remarks 02/12/2020 52,527
Valentine Karen See Remarks 02/13/2020 156,859
Valentine Karen See Remarks 02/10/2020 157,035
Valentine Karen See Remarks 02/11/2020 98,325
Valentine Karen See Remarks 02/10/2020 472,357
Valentine Karen See Remarks 02/11/2020 299,506
Reeve Emma Chief Financial Officer 02/10/2020 1,520
Reeve Emma Chief Financial Officer 02/11/2020 66,308
Reeve Emma Chief Financial Officer 02/10/2020 7,000
Reeve Emma Chief Financial Officer 02/11/2020 302,816
Valentine Karen See Remarks 02/10/2020 162,104
Valentine Karen See Remarks 02/11/2020 98,325
Valentine Karen See Remarks 02/10/2020 472,357
Valentine Karen See Remarks 02/11/2020 299,506
EVNIN ANTHONY B Director 12/13/2019 13,800,000
Venrock Healthcare Capital Partners III, L.P. 10% Owner 12/13/2019 13,800,000
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner 11/12/2019 419,456
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner 11/08/2019 5,287,179
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner 11/12/2019 419,456
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner 11/08/2019 32,512,179
Senderowicz Adrian Chief Medical Officer 11/06/2019 150,048
Senderowicz Adrian Chief Medical Officer 11/06/2019 765,849
Reeve Emma Chief Financial Officer 11/06/2019 442,781
Reeve Emma Chief Financial Officer 11/06/2019 1,410,775
Trojer Patrick Chief Scientific Officer 11/06/2019 231,890
Trojer Patrick Chief Scientific Officer 11/06/2019 1,156,854
Audia James E Director 11/06/2019 417,411
Raythatha Jigar See Remarks 11/06/2019 566,153
Raythatha Jigar See Remarks 11/06/2019 2,911,381
Reeve Emma Chief Financial Officer 11/05/2019 6,610
Reeve Emma Chief Financial Officer 11/05/2019 15,504
Audia James E Director 11/05/2019 34,351
Trojer Patrick Chief Scientific Officer 11/05/2019 6,337
Trojer Patrick Chief Scientific Officer 11/04/2019 551
Trojer Patrick Chief Scientific Officer 11/05/2019 17,256
Trojer Patrick Chief Scientific Officer 11/04/2019 1,500
Trojer Patrick Chief Scientific Officer 10/23/2019 1,653
Trojer Patrick Chief Scientific Officer 10/22/2019 41,977
Trojer Patrick Chief Scientific Officer 10/23/2019 4,559
Trojer Patrick Chief Scientific Officer 10/22/2019 149,802
Audia James E Director 10/23/2019 3,029
Audia James E Director 10/22/2019 75,213
COLUMN GROUP L P 10% Owner 10/03/2019 680,000
COLUMN GROUP L P 10% Owner 10/03/2019 11,319,994
EVNIN ANTHONY B Director 10/03/2019 23,999,997
Senderowicz Adrian Chief Medical Officer 12/13/2018 87,521
TEPPER ROBERT I Director 08/22/2018 79,100
THIRD ROCK VENTURES LP 10% Owner 08/22/2018 79,100
THIRD ROCK VENTURES LP 10% Owner 07/23/2018 4,000,005
TEPPER ROBERT I Director 07/23/2018 4,000,005
ORBIMED ADVISORS LLC 10% Owner 07/23/2018 3,000,000
REGENTS OF THE UNIVERSITY OF CALIFORNIA 10% Owner 07/23/2018 1,999,995
Casdin Capital, LLC 10% Owner 07/23/2018 4,000,005
EVNIN ANTHONY B Director 07/23/2018 2,000,010
Alexandria Venture Investments, LLC 10% Owner 07/23/2018 1,000,005
Flynn James E 10% Owner 07/23/2018 3,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2021
12/31/2020
6.57%
1Q
03/31/2021
09/30/2020
8.78%
2Q
03/31/2021
06/30/2020
13.42%
3Q
03/31/2021
03/31/2020
14.54%
4Q
Load More

Period of Report: 03/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2020
6.57%
1Q
09/30/2020
8.78%
2Q
06/30/2020
13.42%
3Q
03/31/2020
14.54%
4Q
Load More